Clinical Trials Showed the Survival Advantage of Sinus Rhythm STAF: The Strategies for Treatment of AF study – SR maintained in 30% of rhythm control
{"Image DocumentName": "Clinical Trials Showed the Survival Advantage of Sinus Rhythm", "Image ImageDescription": "STAF: The Strategies for Treatment of AF study. SR maintained in 30% of rhythm control patients. Mortality: 2.5% per year in the rhythm control group. 4.9% per year in rate control group. Result was NOT statistically significant. Framingham Heart Study cohort. CHF-STAT. SOLVD. DIAMOND", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}